• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

SHSAX:US

51.26 USD 0.01 0.02%

As of 09:29:30 ET on 01/23/2015.

Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHSAX)

Year To Date: +3.72% 3-Month: +11.74% 3-Year: +30.19% 52-Week Range: 38.14 - 51.26
1-Month: +4.51% 1-Year: +27.68% 5-Year: +20.72% Beta vs SPX: 0.97

Mutual Fund Chart for SHSAX

No chart data available.
  • SHSAX:US 51.26
  • 1M
  • 1Y
Interactive SHSAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SHSAX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 12-21-1999 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / H ERIN XIE
Web Site: www.blackrock.com

Fundamentals for SHSAX

NAV (on 2015-01-23) 51.26
Assets (M) (on 2015-01-23) 5,035.04
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for SHSAX

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2014-12-12) 0.02
Dividend Yield (ttm) 6.72

Fees & Expenses for SHSAX

Front Load 5.25
Back Load 0.00
Current Mgmt Fee 0.72
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.19

Top Fund Holdings for SHSAX

Filing Date: 11/28/2014
Name Position Value % of Total
BlackRock Liquidity Funds Temp 179,297,655 179,297,655 3.734%
Celgene Corp 1,432,538 162,865,245 3.392%
AbbVie Inc 2,240,400 155,035,680 3.229%
Amgen Inc 878,510 145,226,488 3.024%
Alexion Pharmaceuticals Inc 730,717 142,416,743 2.966%
Merck & Co Inc 2,334,800 141,021,920 2.937%
UnitedHealth Group Inc 1,306,382 128,848,457 2.683%
Johnson & Johnson 1,169,900 126,641,675 2.637%
Actavis plc 440,546 119,216,153 2.483%
Novartis AG 1,176,600 113,780,133 2.369%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil